Search Results for: WSE

Medinice invests after its debut on the WSE
|

Medinice invests after its debut on the WSE

Medinice, a Polish company developing innovative projects for cardiology and cardiac surgery, has signed a preliminary agreement for the purchase of shares in a company which holds rights to globally patented cardiac surgery technology. The promised agreement is to be signed by the end of March 2021. Medinice invests in a company with a patent…

New company on the WSE?

New company on the WSE?

Inno-Gene SA, a company operating in the area of medical diagnostics, has announced the commencement of activities aimed at transferring shares from NewConnect to the WSE main market. Currently, the issuer’s management board has started talks with brokerage houses and law firms which are to carry out the whole process. Purpose of the transition to…

Pharmena: From NewConnect on the WSE, counts on PLN 15.3 million
|

Pharmena: From NewConnect on the WSE, counts on PLN 15.3 million

Pharmena, a Polish biotechnology company, intends to move from NewConnect to the WSE. Subsequently, it plans to raise PLN 15.3 million from the issue of series E shares. It will allocate these funds to the development of its operations. The transfer of trading on the WSE is to take place before 3 April. On 4-23…

PolTREG debuts on the Warsaw Stock Exchange main market
|

PolTREG debuts on the Warsaw Stock Exchange main market

PolTREG will debut on the main market of the Warsaw Stock Exchange (WSE) today, Tuesday, 23 November. The funds raised through the share issue will enable the company to develop key strategic objectives, such as clinical trials of cell therapies for the treatment of type 1 diabetes. The debut on the WSE was preceded by…

Zago Capital raising €100m
| |

Zago Capital raising €100m

Zago Capital, a newly-established polish investment group with a focus on wellness, fitness, personal care, organics, nutrition, dietary supplements, micro-biome and cosmetic products, is planning to raise €100m by mid-2023. The fund now already has 10-15% of this amount. Most of the funds will be most likely invested in Poland, where it receives the most applications – the company is targeting…

Further personnel changes in the pharmaceutical industry

Further personnel changes in the pharmaceutical industry

In May, we already informed about two important personnel changes, and this is not the end! Mabion makes key changes related to the company’s management. The company appointed Krzysztof Kaczmarczyk to the position of the President of the Management Board. Moreover, from 2022, the European Union Pharmaceutical Group (PGEU) will have a new president. Kaczmarczyk…

Telemedycyna Polska: almost 100% revenue increase in Q4 2020
|

Telemedycyna Polska: almost 100% revenue increase in Q4 2020

In Q4 2020, consolidated sales revenues of Telemedyna Polska increased by 96% y-o-y and amounted to PLN 2m. In the entire 2020, the sales revenues of the company, which specialises in telecardiology services for individual patients and for medical facilities across the country, amounted to PLN 5m and increased by 0.2% compared to the previous…

Diagnostyka as MedApp partner

Diagnostyka as MedApp partner

MedApp S.A. develops the Digital Clinic service. As part of this, the company signed a partnership agreement with the largest network of diagnostic laboratories in Poland – Diagnostyka company. The cooperation between the two companies is intended to allow patients and doctors remote access to the results of examinations carried out by Diagnostyka. Laboratory examinations…

Captor Therapeutics: Dr Tom Shepherd appointed President of the Management Board

Captor Therapeutics: Dr Tom Shepherd appointed President of the Management Board

Captor Therapeutics, a biopharmaceutical company working to develop drugs for cancer and autoimmune diseases, has announced the appointment of President of the Management Board. He has been appointed as Dr Tom Shepherd. Dr Shepherd joined Captor in early December 2019. At that time, he held the position of business development director. Last week, the company…

Wieslaw Zyznowski and Mercator Medical: Success in times of pandemic
|

Wieslaw Zyznowski and Mercator Medical: Success in times of pandemic

While many industries are experiencing the greatest difficulties of the last years, Wieslaw Zyznowski, CEO of Mercator Medical, went from being a millionaire to a billionaire during the pandemic. As reported by Puls Biznesu, his wealth at its peak increased by as much as 3,500%. The fourth quarter also brought high increases. Wieslaw Zyznowski the…